FAIM2 was originally discovered to antagonize Fas-mediated cell death [36], and has been identified as a protective factor in a number of diseases [42–46] as well as a factor promoting tumor growth and aggressiveness of various cancers [47–50]. Here, FAIM2 is linked to cancer.